Denali Therapeutics Reports First Quarter 2019 Financial Results by bizlift | May 7, 2019 | Denali Press Releases, Portfolio News
Denali Therapeutics Reports Full Year 2018 Financial Results and Business Highlights by bizlift | Mar 12, 2019 | Denali Press Releases, Portfolio News
Denali Therapeutics Announces First Patient Dosed in Phase 1B Study of DNL747 for Alzheimer’s Disease by bizlift | Feb 15, 2019 | Denali Press Releases, Portfolio News
Denali Therapeutics Announces First Patient Dosed in Phase 1B Study of DNL747 for ALS by bizlift | Jan 8, 2019 | Denali Press Releases, Portfolio News
Denali Therapeutics Announces First Patient Dosed in Phase 1B Study of DNL201 for Parkinson’s Disease by bizlift | Dec 10, 2018 | Denali Press Releases, Portfolio News
